Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428482 | PMC |
| http://dx.doi.org/10.3399/bjgp19X702173 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Colorectal cancer (CRC) claims 900,000 lives per year. Colonoscopy offers reliable detection, but with low patient adherence rates. To significantly reduce CRC incidence and mortality, a more convenient screening measure for advanced precancerous lesions (APL) and CRC is urgently needed.
View Article and Find Full Text PDFEffect of Gut Dysbiosis on Onset of GI Cancers.
Cancers (Basel)
December 2024
Division of Hematology and Oncology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Dysbiosis in the gut microbiota plays a significant role in GI cancer development by influencing immune function and disrupting metabolic functions. Dysbiosis can drive carcinogenesis through pathways like immune dysregulation and the release of carcinogenic metabolites, and altered metabolism, genetic instability, and pro-inflammatory signalling, contributing to GI cancer initiation and progression. infection and genotoxins released from dysbiosis, lifestyle and dietary habits are other factors that contribute to GI cancer development.
View Article and Find Full Text PDFColorectal cancer screening based on predicted risk: a randomized controlled trial.
Am J Gastroenterol
January 2025
Unisanté, University Center for Primary Care and Public Health, University of Lausanne, Route de Berne 113, 1010 Lausanne, Switzerland.
Introduction: Colorectal cancer (CRC) screening relies primarily on colonoscopy and fecal immunochemical testing (FIT). Aligning utilization of these options with individual CRC risk may optimize benefit with lower risks, individual burden, and societal costs. We studied the effect of communicating personalized CRC risk and corresponding screening recommendations on risk-appropriate screening uptake in an organized screening setting.
View Article and Find Full Text PDFComment on "Fecal Immunochemical to Detect Colorectal Neoplasia in Lynch Syndrome: A Prospective Multicenter Study".
Am J Gastroenterol
January 2025
Department of Neurology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Effectiveness of the Korean National Cancer Screening Program in Reducing Colorectal Cancer Mortality.
Cancers (Basel)
December 2024
National Cancer Control Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Background: Whether colorectal cancer (CRC) screening with a fecal immunochemical test (FIT) reduces mortality remains unclear. In South Korea, CRC screening with a FIT for individuals aged ≥ 50 years has been part of the Korean National Cancer Screening Program (KNCSP) since 2004. The aim of this study was to evaluate the effectiveness of the KNCSP in reducing CRC-specific mortality.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!